top of page
Fluidx Wave Top_edited.png
IMPASSSyringe.png
IMPASS logo TM.png

Consistent. Fast. Complete.

*

The IMPASS Embolic Device is a novel, neurovascular embolization agent with deep, distal penetration ideal for oncology and middle meningeal artery embolization.  It enables the user to flow embolic material to the target vasculature without special techniques, or dilutions. 

  • No toxic and painful DMSO solvents

  • Simple preparation (ready-to-use syringe) with no limit to working time

  • Radiopaque material allows for real-time visualization

  • Controllable material delivery

  • Consistent distal penetration without dilution

  • No risk of catheter entrapment

  • Deliverable through standard neurovascular microcatheters

  • No special delivery catheter or delivery systems required

  • Durable occlusion, independent of patient’s hemostatic condition

†

†

*
*
*
*
*

Limitations of Current Embolics

Embolic products available today can be difficult to use and unpredictable.

Microspheres & Particles

  • Off-Target Embolization

  • Proximal Reflux

  • Poor Visualization

  • Catheter Clogging

Coils

  • Inconsistent Embolization

  • Recanalization

  • Often require multiple coils to achieve desired occlusion (time, cost)

  • Risk of migration

Liquids

  • Special preparation & delivery technique

  • Toxicity of DMSO

  • Customization of NBCA

  • Catheter entrapment

  • Reflux, obstruction of catheter tip

Simple Preparation

Ready to use in under 30 seconds with no additional equipment or shaking.

Distal Penetration and Visibility

Pre-clinical delivery of IMPASS Embolic in an intercostal artery, simulating a middle meningeal artery (MMA) embolization.

IMPASS_BG.gif

Pre-clinical delivery of IMPASS Embolic in a middle meningeal artery (MMA).

Mechanism of Action

Mechanism of Action 2.png

  • The IMPASS Embolic Device contains a water-based ionic polymer solution in a delivery syringe

  • Counterions in the solution prevent polymer interactions in the syringe

  • When delivered to the bloodstream, the counterions immediately dissipate, allowing solidification of the polymer solution via ionic bonding

* Data on file. Fluidx Medical Technology, Inc.

† Based on in vivo study. Data on file. Fluidx Medical Technology, Inc. In vivo results are not necessarily indicative of clinical results.

The IMPASS Embolic Device is under development and does not have marketing clearance or approval in any market at this time. 

Limitations of Current Embolics

Embolic products available today can be difficult to use and unpredictable.

Microspheres & Particles

  • Off-Target Embolization

  • Proximal Reflux

  • Poor Visualization

  • Catheter Clogging

Coils

  • Inconsistent Embolization

  • Recanalization

  • Often require multiple coils to achieve desired occlusion (time, cost)

  • Risk of migration

Liquids

  • Special preparation & delivery technique

  • Toxicity of DMSO

  • Customization of NBCA

  • Catheter entrapment

  • Reflux, obstruction of catheter tip

bottom of page